Peripheral Magnetic Stimulation and Transcranial TMS at BrainHealth Solutions | Costa Mesa, California
Peripheral Magnetic Stimulation
Transcranial TMS for Pain
What Is Magnetic Neuromodulation?
Magnetic stimulation uses rapidly changing magnetic fields to induce electrical currents in excitable tissue. The clinical effect depends on where the magnetic field is delivered. Peripheral magnetic stimulation is directed toward peripheral nerves, while transcranial magnetic stimulation delivers pulses through a coil placed against the scalp to influence activity in targeted cortical networks.
Peripheral Magnetic Stimulation for Chronic Pain
Peripheral magnetic stimulation directs magnetic pulses toward nerves outside the brain and spinal cord. The FDA-cleared MagVenture Pain Therapy system is intended to stimulate peripheral nerves for the relief of chronic intractable, post-traumatic, and post-surgical pain in adults.
At BHS, peripheral magnetic stimulation may be considered when a patient’s pain pattern, diagnosis, examination, and treatment history suggest that targeting peripheral neural structures is clinically appropriate.
Transcranial TMS for Chronic Pain
Transcranial magnetic stimulation uses a coil positioned on the scalp to stimulate specific regions of the cerebral cortex. Rather than “resetting” pain circuits, a more accurate description is that repeated stimulation may modulate cortical excitability and networks involved in pain perception and pain modulation.
Among the best-studied approaches is high-frequency repetitive TMS (rTMS) applied to the primary motor cortex on the contralateral side to the painful side. Evidence-based international guidelines have rated this approach as having definite efficacy for neuropathic pain. However, results vary by diagnosis, target, stimulation protocol, treatment duration, and individual patient factors.
Important regulatory distinction: although TMS devices have FDA-cleared indications in psychiatry and neurology, transcranial TMS specifically for chronic pain is generally considered an off-label use in the United States.
Why Offering Both Approaches Matters
Chronic pain is not a single biological process. Some patients have a predominantly peripheral pain generator, while others have neuropathic, central, or mixed mechanisms. BHS’s ability to provide both peripheral and transcranial magnetic stimulation gives clinicians a broader set of neuromodulation options when developing an individualized treatment plan.
- Peripheral magnetic stimulation directed toward affected peripheral nerves when clinically appropriate
- Transcranial TMS targeting cortical networks involved in pain processing
- Evaluation and treatment of coexisting depression or other psychiatric symptoms when clinically appropriate
- Integration of neuromodulation with the patient’s existing pain-management plan
What Types of Pain Have Been Studied with Transcranial TMS?
Clinical studies of rTMS have included patients with several chronic pain conditions, including:
- Peripheral neuropathic pain
- Central neuropathic pain
- Central post-stroke pain
- Pain associated with nerve injury
- Phantom limb pain
- Complex regional pain syndrome (CRPS)
- Fibromyalgia
- Selected facial and craniofacial neuropathic pain syndromes
The strength of evidence is not the same for every condition. Inclusion in research does not mean that transcranial TMS is FDA-cleared or established as standard care for that diagnosis.
The BHS Evaluation Process
Treatment begins with a clinician’s evaluation designed to clarify the pain mechanism, review prior therapies, identify safety considerations, and determine whether magnetic neuromodulation is appropriate.
- Pain diagnosis, location, duration, and functional impact
- Previous medications, procedures, rehabilitation, and other pain treatments
- Neurological and psychiatric history
- Review of implanted devices and metallic objects
- Assessment of seizure risk and medications that may affect seizure threshold
- Pain and functional outcome measures
- Discussion of realistic treatment goals and alternatives
For transcranial TMS, treatment planning may also include determining the motor threshold and identifying the cortical stimulation target. For peripheral protocols, the treatment target and positioning are selected according to the peripheral pain location and the protocol being used.
What Happens During Treatment?
Patients remain awake during magnetic stimulation. The coil is positioned over the selected peripheral or transcranial target, and magnetic pulses are delivered according to the treatment protocol. Patients may hear clicking sounds and feel tapping, muscle activation, or local sensations during stimulation.
Session length, pulse number, stimulation frequency, and total number of treatments vary by protocol. Unlike established TMS protocols for major depressive disorder, there is no single universally accepted transcranial TMS treatment course for chronic pain.
How Effective Is Transcranial TMS for Pain?
Research findings are encouraging, particularly for neuropathic pain, but response rates vary substantially. For this reason, BHS should avoid promising a universal percentage of patients who will improve.
- Type and cause of pain
- Peripheral versus central pain mechanisms
- Brain region or peripheral nerve targeted
- Stimulation frequency, intensity, and number of sessions
- Concurrent medications and treatments
- Individual neurobiology and comorbid conditions
Some patients may experience meaningful reductions in pain or improved function, while others may experience little or no benefit.
How Quickly Can Improvement Occur?
Clinical studies have reported pain reduction during and after courses of stimulation, but there is no reliable timetable that applies to every patient. Some individuals notice changes during the treatment period, while others may require multiple sessions before a meaningful response can be assessed.
How Long Can Benefits Last?
Analgesic effects may persist beyond an individual treatment session in some patients, but durability varies. Long-term maintenance schedules for transcranial TMS in chronic pain have not been standardized. Additional or maintenance treatments may be considered based on clinical response and the protocol used.
Potential Advantages of Magnetic Stimulation
- Non-invasive treatment
- No surgical incision
- Usually no anesthesia
- No systemic administration of medication
- Patients remain awake during treatment
- Typically, little or no post-treatment downtime
Because magnetic stimulation does not introduce a drug into the bloodstream, it avoids many medication-related systemic interactions.
Safety and Possible Side Effects
TMS is generally considered well-tolerated when patients are appropriately screened, and treatment is administered according to accepted safety procedures. Common effects of transcranial treatment may include transient scalp discomfort, headache, tapping sensations, or local muscle twitching. Seizure is a rare but important potential adverse event.
Particular consideration may be needed for patients with:
- Certain implanted metallic or electronic devices
- Metallic objects near the stimulation area
- A history or increased risk of seizures
- Neurological disorders
- Medications that may alter seizure threshold
- Pregnancy
These considerations are not automatically absolute contraindications in every patient; the treating physician determines eligibility based on the device, protocol, and individual risk profile.
Can Magnetic Stimulation Replace Pain Medication?
Magnetic stimulation is not an automatic substitute for a patient’s current pain medications. It may be incorporated into a broader pain-management strategy. Any reduction or discontinuation of prescribed medication should be performed only under medical supervision.
Pain, Depression, Sleep, and Brain Health
Chronic pain frequently overlaps with depression, anxiety, and sleep disturbance. These conditions can amplify one another and may affect treatment response. BHS’s psychiatric and neuromodulation expertise allows clinicians to evaluate both pain-related symptoms and coexisting psychiatric conditions when developing a treatment strategy.
Insurance Coverage
Insurance coverage depends on the indication, device, protocol, payer policy, and the patient’s individual benefits. Coverage of TMS for major depressive disorder does not automatically mean that transcranial TMS for chronic pain is covered.
Cost of Treatment
The cost of treatment depends on whether a peripheral or transcranial protocol is used, the number of sessions, insurance benefits when applicable, and the individualized treatment plan. BHS can provide a patient-specific estimate after clinical consultation and benefit verification.
Advanced Neuromodulation at BrainHealth Solutions
BrainHealth Solutions uses multiple magnetic stimulation technologies and can provide both peripheral pain protocols and transcranial TMS protocols. This dual capability supports an individualized approach that considers whether pain may be better addressed through peripheral nerve stimulation, central neuromodulation, treatment of a coexisting psychiatric condition, or a combination of strategies.
Which Magnetic Stimulation Approach Is Right for Me?
The appropriate approach depends on the origin and characteristics of the pain. Some patients may be candidates for stimulation directed toward peripheral nerves. Others – particularly those with neuropathic or centrally mediated pain – may be evaluated for a transcranial neuromodulation approach. Some patients may have overlapping peripheral and central pain mechanisms.
A physician evaluation at BrainHealth Solutions can help determine whether peripheral magnetic stimulation, transcranial TMS, or another treatment approach is most appropriate.
Frequently Asked Questions
Is magnetic stimulation for chronic pain FDA-cleared?
It depends on the protocol. The MagVenture Pain Therapy system has FDA clearance to stimulate peripheral nerves for the relief of chronic intractable, post-traumatic, and post-surgical pain in adults. By contrast, transcranial TMS applied specifically to treat chronic pain is generally an off-label use in the United States.
Is TMS safe?
TMS is generally well tolerated when patients are appropriately screened, and treatment is administered according to accepted safety procedures. Common effects can include temporary scalp discomfort and headache. Seizures are rare but are an important potential risk.
How many treatments will I need?
The number of treatments depends on the diagnosis, treatment target, protocol, clinical response, and whether peripheral or transcranial stimulation is being used. There is no single universally established transcranial TMS treatment course for chronic pain.
How quickly does magnetic stimulation work for pain?
Responses vary. Some patients in clinical studies have experienced changes during a treatment course, but there is no predictable timeline that applies to every patient.
Can TMS eliminate chronic pain?
No treatment can guarantee the elimination of chronic pain. The goal may be reduced pain intensity, better function, improved sleep, improved mood, or improved quality of life, depending on the patient’s condition.
Can I stop my pain medication if treatment works?
Medication changes should be made only with the clinician prescribing those medications. Magnetic stimulation may complement a broader pain-management strategy rather than replace all other treatments.
Learn More About Neuromodulation in Costa Mesa
If chronic pain continues to interfere with quality of life despite conventional treatment, BrainHealth Solutions can evaluate whether magnetic neuromodulation is appropriate. The BHS team can review symptoms, previous treatments, medical history, and treatment goals and discuss the potential benefits, limitations, risks, regulatory status, and financial considerations of both peripheral and transcranial approaches.
Individual results vary. Transcranial TMS for chronic pain may involve off-label use of an FDA-cleared medical device. A medical consultation is required to determine whether treatment is appropriate.
Editorial Fact-Check Notes and Sources
The yellow boxes above are editorial flags for information that should be verified internally before publication. The clinical and regulatory revisions in this document were checked against the sources below.
- U.S. Food and Drug Administration, 510(k) K230014, MagVenture Pain Therapy (2023). FDA clearance states that the device is intended to stimulate peripheral nerves for relief of chronic intractable, post-traumatic, and post-surgical pain in adults.
- Lefaucheur JP, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018). Clin Neurophysiol. 2020;131(2):474-528. The guideline reports Level A evidence for high-frequency rTMS of the primary motor cortex contralateral to the painful side for neuropathic pain.
- Leung A, et al. Transcranial Magnetic Stimulation for Pain, Headache, and Comorbid Depression: INS-NANS Expert Consensus Panel Review and Recommendation. Neuromodulation. 2020. Provides expert review and recommendations regarding TMS for neuropathic pain and headache and identifies the need for further outcome and cost-effectiveness evidence.
